Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Negrin

Showing results (141-150 of 260) with videos related to

Pageof 26
Sort By:
Blood|September 1, 1994
Granulocyte colony-stimulating factor after allogeneic bone marrow transplantationJ R Schriber, N J Chao, G D Long, et al.
Cancer Research|December 17, 2010
CXCL12 mediates immunosuppression in the lymphoma microenvironment after allogeneic transplantation of hematopoietic cellsChristoph Dürr, Dietmar Pfeifer, Rainer Claus, et al.
American Journal of Obstetrics and Gynecology|November 6, 2007
A novel technique for the enrichment of primary ovarian cancer cellsJohn K Chan, Chad A Hamilton, Ellen M Anderson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: preliminary dataS J Horning, N J Chao, R S Negrin, et al.
Cancer|June 20, 2001
Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignanciesT M Cao, C Kusnierz-Glaz, F Valone, et al.
Blood|April 19, 2017
Invariant natural killer T cells ameliorate murine chronic GVHD by expanding donor regulatory T cellsJing Du, Katelyn Paz, Govindarajan Thangavelu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 16, 2010
Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial responseMarcie R Tomblyn, Marian Ewell, Christopher Bredeson, et al.
Blood Advances|September 8, 2020
Recipient-specific T-cell repertoire reconstitution in the gut following murine hematopoietic cell transplantPingping Zheng, John Tamaresis, Govindarajan Thangavelu, et al.
Experimental Hematology|February 26, 2005
CD34, CD4, and CD8 cell doses do not influence engraftment, graft-versus-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignanciesThai M Cao, Ruby M Wong, Kevin Sheehan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 6, 2019
Donor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid NeoplasmsRupa Narayan, Jonathan E Benjamin, Omid Shah, et al.
Pageof 26

Showing results (141-150 of 260) with videos related to

Sort By:
Pageof 26
Blood|September 1, 1994
Granulocyte colony-stimulating factor after allogeneic bone marrow transplantationJ R Schriber, N J Chao, G D Long, et al.
Cancer Research|December 17, 2010
CXCL12 mediates immunosuppression in the lymphoma microenvironment after allogeneic transplantation of hematopoietic cellsChristoph Dürr, Dietmar Pfeifer, Rainer Claus, et al.
American Journal of Obstetrics and Gynecology|November 6, 2007
A novel technique for the enrichment of primary ovarian cancer cellsJohn K Chan, Chad A Hamilton, Ellen M Anderson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: preliminary dataS J Horning, N J Chao, R S Negrin, et al.
Cancer|June 20, 2001
Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignanciesT M Cao, C Kusnierz-Glaz, F Valone, et al.
Blood|April 19, 2017
Invariant natural killer T cells ameliorate murine chronic GVHD by expanding donor regulatory T cellsJing Du, Katelyn Paz, Govindarajan Thangavelu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 16, 2010
Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial responseMarcie R Tomblyn, Marian Ewell, Christopher Bredeson, et al.
Blood Advances|September 8, 2020
Recipient-specific T-cell repertoire reconstitution in the gut following murine hematopoietic cell transplantPingping Zheng, John Tamaresis, Govindarajan Thangavelu, et al.
Experimental Hematology|February 26, 2005
CD34, CD4, and CD8 cell doses do not influence engraftment, graft-versus-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignanciesThai M Cao, Ruby M Wong, Kevin Sheehan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 6, 2019
Donor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid NeoplasmsRupa Narayan, Jonathan E Benjamin, Omid Shah, et al.
Pageof 26